Vital Farms (VITL) Teardown: Numbers, Model, Bear Case

$759 million of revenue in FY2025. A 37.6% gross margin in a category where commodity competitors run ~29%. A farm network that doubled from 300 to 600 family farms in two years. Then Q1 2026 arrives and gross margin falls to 28.3% - a 1,020-basis-point collapse - and the company posts its first operating loss since it was barely profitable in FY2021.

That Q1 2026 print is the number that breaks the Vital Farms story open. Not because the franchise is broken. Because it reveals the structural cost embedded in the model that makes it work: the pasture-raised standard that commands the premium is the same standard that makes these birds most exposed to avian flu, and the $82M being spent on a second egg-packing plant that doesn't open until 2027 drags cash and margin today while the payoff sits two years out.

This is the teardown of a genuinely premium food brand running into the two-sided bet at the core of its own business model.

Section 1 - The snapshot

Metric	FY2025	Q1 FY2026 (crack)	Q1 FY2025 (prior year)
Revenue	$759.4M	$187.2M	$162.2M
Revenue YoY	+25.3%	+15.4%	n/a
Gross margin	37.6%	28.3%	38.5%
Operating income (loss)	$88.4M (11.6%)	-$2.3M (-1.2%)	$21.8M (13.4%)
Net income (loss)	$66.3M	-$1.5M	$16.9M
Diluted EPS	$1.44	-$0.03	$0.37
Adjusted EBITDA	$114.0M	$5.0M	$27.5M
Operating cash flow	$33.7M	-$18.6M (YTD)	n/a
Inventory	$66.5M	$90.2M	n/a
Cash + marketable securities	$113.4M	$51.4M	n/a
Long-term debt	$0 (net cash)	$0	n/a

The five-year arc:

Fiscal year	Revenue	YoY growth	Gross margin	Operating margin	Operating cash flow
FY2021	$260.9M	n/a	31.8%	0.0%	$17.7M
FY2022	$362.1M	+38.8%	30.2%	0.6%	-$8.1M
FY2023	$471.9M	+30.3%	34.4%	7.0%	$50.9M
FY2024	$606.3M	+28.5%	37.9%	10.5%	$64.8M
FY2025	$759.4M	+25.3%	37.6%	11.6%	$33.7M
Q1 FY2026 (annualized)	$187.2M qtr	+15.4%	28.3%	-1.2%	-$18.6M qtr

Section 2 - The business model: how they actually make money

Vital Farms is not a DTC brand and not a subscription business. It is a branded packaged-food company that sells premium pasture-raised shell eggs through grocery shelves, with a supply chain built around more than 600 contracted small family farms.

The model has three interlocking pieces. First, contracted farmers raise laying hens under Vital Farms' pasture-raised standard: each hen gets at least 108 square feet of outdoor space and daily outdoor access. Farmers operate on 4-to-5-year buy-sell contracts under which Vital Farms is obligated to purchase all egg production at prices adjusted quarterly for feed costs (corn and soybean meal). That cost pass-through protects farmers but exposes Vital Farms to the quarterly rhythm of commodity input prices.

Second, eggs are collected from the farm network and processed at Egg Central Station in Springfield, Missouri - a 153,000-square-foot, SQF Excellent-rated facility now capable of packing more than 7.5 million eggs per day (expanded in 2025 with an additional Moba grading system). A second facility, Vital Crossroads in Seymour, Indiana, is under construction and expected to be operational in early 2027. That facility is the capacity bet behind the FY2025 $82M capex surge.

Third, shell eggs move to retail through distributors and direct retail relationships. In FY2025, mainstream grocery represented 62% of retail dollar sales (Kroger, Walmart, Target, Publix, Albertsons); natural channel represented 38% (Whole Foods via UNFI, Sprouts). Foodservice was 3% of net revenue. There is no material direct-to-consumer revenue.

Shell eggs generated $733.2M of FY2025 net revenue, or 96.6% of the total. Butter was the remaining 3.4% (~$26M), and Vital Farms announced on May 7, 2026 that it will wind down the butter business entirely by the end of FY2026, becoming a pure-play egg company. The butter exit simplifies the model and the supply chain, which had carried international sourcing risk and tariff exposure that the 10-K FY2025 flagged explicitly.

Where does the 37.6% gross margin come from? The branded premium over commodity and even other specialty eggs. The 10-K FY2025 states the company is "either the number one or two egg brand by retail dollar sales for branded eggs with nine of our ten largest retail customers" against a U.S. pasture-raised retail egg market of approximately $1.3B in 2025. The premium is defended by the Certified B-Corp and Public Benefit Corporation positioning, the farm traceability story (you can look up your farm on the carton), and roughly ~16 million U.S. households that have tried the product. That brand pull lets Vital Farms hold a price point 2-4x conventional eggs while running ~37% gross margins versus the ~29% Cal-Maine Foods reports on its conventional egg business.

Here is what the pasture-raised-eggs demand culture looks like from the consumer side. These videos are category and sentiment signals, not load-bearing financial facts.

@paulsaladinomd2

Pasture raised > regular eggs

♬ original sound - Paul Saladino

@paulsaladinomd2 (Paul Saladino), 775K plays, 44.8K likes. The demand signal: high-reach nutrition creators treating pasture-raised as the default. Social signal only.

@zephzoid

Welcome to food in 2026: where labels mean next to nothing and grocery stores can't be trusted. Turns out one of the most popular Pasture-Raised Eggs - Vital Farms - has extremely omega-6 polyunsaturated fat (PUFA or Linoleic acid). While the chickens are raised on pasture…they are also fed corn and soy. Billions in subsidies go towards these crops which makes production cheap but also makes them pro-inflammatory. Why this is devastating? These are some of the most widely available "high-quality" eggs. And test results show they aren't all the much different from many cage-free/free range eggs, but greenwashed marketing pushes the price up 2-4x. The future of eggs - local farms > grocery stores - corn and soy free is the standard - testing becomes a necessity Talk to your farmer. Ask about the feed. This is what we should be buying based on not marketing claims.

♬ original sound - Zephyr Zoidis

@zephzoid (Zephyr Zoidis), 365.5K plays, 20.6K likes, 1,117 comments. The risk signal: the very transparency that makes the brand credible also invites scrutiny. Social signal only.

@regenroots_

RegenRoots - Real roots. Real pasture. Real eggs. Take a chance..🌱🥚 #PastureRaisedEggs #regenerativeagriculture #nongmo

♬ original sound - RegenRoots_

@regenroots_, 219.3K plays, 16.1K likes. Smaller pasture-raised producers competing for the same premium shelf position. The category demand is real; the competition is intensifying. Social signal only.

Section 3 - Strengths: the moat that is real

1. Price and volume both drove growth - the brand is not a unit-share story. The FY2025 10-K decomposes the $153.1M revenue increase: $74.9M came from price/mix (49%) and $78.3M from volume (51%). That is the clearest line a CFO can underwrite when evaluating whether a premium position is durable: roughly half the growth came from pricing power, not just selling more units. Compare this to a commodity egg producer, where nearly all growth is volume or spot-price swing. In Q1 2026, price/mix turned negative for the first time (-$9.7M), which is the single most important directional signal for the recovery - restoring it is the whole Q2-Q3 2026 story. Source: 10-K FY2025 MD&A; Q1 2026 earnings release (May 7, 2026).

2. A structural gross margin premium over conventional egg producers. Vital Farms ran 37.6% gross margin in FY2025. Cal-Maine Foods, the dominant conventional egg producer, reported a gross margin of approximately 29% on its Q4 FY2024 results. That ~8-percentage-point structural premium is what the pasture-raised brand position and the price premium generate on a sustained basis. Even in the Q1 2026 oversupply quarter, the 28.3% margin is roughly at par with where Cal-Maine runs in a normal period - meaning the floor in a bad quarter is roughly the ceiling for a conventional-egg competitor. Source: 10-K FY2025; Cal-Maine Foods Q4 FY2024 results (egg-news.com, July 23, 2024); 10-Q Q1 FY2026.

3. A clean balance sheet that funds the capital cycle without debt. At FY2025 year-end, Vital Farms carried essentially zero financial debt: $10.8M in finance-lease liabilities against $113.4M in cash and marketable securities, for a net cash position of approximately $102.6M. The $82M FY2025 capex program for Vital Crossroads was funded from operating cash flow and existing cash, not borrowed money. The $60M JPMorgan revolving credit facility was undrawn at both FY2025 year-end and Q1 2026 close. For a company building a second large-scale egg-packing facility, zero debt is a genuine operational advantage: the capital cycle does not carry interest rate risk, and a second bad quarter does not create a covenant breach. Source: 10-K FY2025, Notes to Financial Statements; 10-Q Q1 FY2026.

4. Scale and distribution depth that took a decade to build. More than 24,000 retail doors carrying the product, with #1 or #2 brand position by retail dollar sales at nine of the company's ten largest retail customers. The farm network doubled from 300+ farms (FY2023) to 600+ farms (FY2025), providing supply depth that a new entrant cannot replicate quickly. The pasture-raised standard (108 sq ft per hen) limits how quickly any competitor can scale, because the land and barn requirements are structurally more demanding than cage-free or conventional operations. Egg Central Station's SQF Excellent certification and 7.5 million eggs/day capacity are infrastructure that took years to develop. Source: 10-K FY2025 Item 1.

Section 4 - Weaknesses: the cracks in the 10-Q

1. The Q1 2026 margin collapse is not a one-line blip - it is a mechanism. When the pasture-raised subcategory runs an oversupply, Vital Farms cannot simply cut the per-dozen shelf price to move volume - that would erode the premium position that justifies the cost structure. Instead, the company moved excess inventory into industrial breaker channels at prices CFO Thilo Wrede disclosed as "as low as $0.10 per dozen." Selling shell eggs at $0.10/dozen when your gross margin is built on a $5.00/dozen retail price produces exactly the 1,020-basis-point gross margin collapse that Q1 2026 shows. The verbatim Q1 2026 earnings release: "The price/mix decline was driven by an oversupply of egg inventory, which resulted in increased sales to breaker and wholesale channels at lower prices, reducing gross profit by an estimated $4.9 million." The full-year 2026 cost of managing the oversupply via breaker sales and voluntary farmer contract amendments (delaying flock placements) is estimated at $32M - enough on its own to explain why FY2026 Adjusted EBITDA guidance was cut from $105M-$115M to $0-$10M. Source: Q1 2026 earnings press release and earnings call transcript (May 7, 2026, investors.vitalfarms.com).

2. The pasture-raised standard that earns the premium is also the structural HPAI exposure. The FY2025 10-K Item 1A risk factor states: "agricultural diseases such as HPAI or EDS have resulted and could in the future result in supply shortages and price increases across the egg market, including shortages of eggs on shelves at our retail customers." What the risk factor does not say explicitly is the directional asymmetry: in FY2024-2025, industry-wide HPAI depopulation (40+ million birds in 2024, per peer commentary) lifted conventional egg prices and created demand tailwinds for premium brands. When HPAI subsided and production capacity recovered, the same subcategory that had benefited from the supply shock overbuilt its way into the Q1 2026 oversupply. Vital Farms' outdoor-bird model means its flock carries structurally greater HPAI exposure than caged or cage-free alternatives. In FY2024, one Vital Farms farm experienced a direct HPAI outbreak for the first time - the risk moved from industry-level abstraction to farm-level event. In that same year, nine farms in the Midwest experienced Egg Drop Syndrome (EDS), a new disease risk not disclosed in prior filings. Source: 10-K FY2024 and FY2025 Item 1A risk factors.

3. Customer concentration: UNFI at 22% of FY2025 revenue is a single-point dependency. The FY2025 10-K discloses that Customer A (identified elsewhere as UNFI, the distributor that serves Whole Foods and other natural retailers) accounted for 22% of FY2025 net revenue, or approximately $167M concentrated in one relationship. A second unnamed customer accounted for approximately 10%. Four customers each represent 10-16% of accounts receivable. The 10-K Item 1A is direct: "A limited number of distributors represent a substantial portion of our sales, and disruptions affecting our significant distributors or our relationships with such distributors may adversely affect our results of operations." This is a branded packaged-food company, not a DTC brand with direct customer relationships - the distributor concentration is the channel concentration, and it does not diversify easily. Source: 10-K FY2025 Item 1A.

4. $82M in FY2025 capex on a facility that is not operational until 2027. Vital Crossroads is the right long-term infrastructure investment for a company targeting $1B in egg revenue. It is also spending that arrives in the P&L before it generates a return. FY2025 operating cash flow fell to $33.7M from $64.8M in FY2024, while capex tripled from $28.6M to $82M - the combination left free cash flow deeply negative. PP&E on the balance sheet nearly doubled from $84.5M to $160.6M. When Q1 2026 also produced negative operating cash flow (-$18.6M), the company was drawing down its cash and marketable securities buffer ($113.4M at FY2025 year-end to $51.4M at Q1 2026 close). Management cut FY2026 capex guidance from $140M-$150M to $70M-$75M on May 7, 2026, citing a "slowdown of the work on Seymour and the pause in the build-out of accelerator farms" - itself a signal that demand growth has slowed below the facility build-out pace. Source: 10-K FY2025 MD&A; Q1 2026 earnings release.

Section 5 - Opportunities and threats

The opportunity side is clearer than the threat side, which is a good sign for a franchise in a cleanup quarter.

The mainstream-grocery penetration story is still early. In FY2025, mainstream grocers represented 62% of Vital Farms' retail dollar sales - up from 60% in FY2024, while natural channel fell from 40% to 38%. That shift reflects the brand moving beyond its Whole Foods heritage into Kroger, Walmart, Target, and Publix at growing velocity. The U.S. pasture-raised egg market was approximately $1.3B in 2025 per the 10-K FY2025, and Vital Farms' ~$760M revenue implies commanding market share but also a category that has room to expand as consumers trade up. The butter wind-down accelerates the focus on this core expansion.

The Vital Crossroads facility, once operational, unlocks the supply growth the company has been pre-building on the farm side. The 600+ farm network was recruited for a production base that Egg Central Station cannot fully process at current capacity. Vital Crossroads adds that processing capacity in 2027, when the oversupply in the subcategory may have normalized - positioning Vital Farms to take share from the same capacity additions that created the 2026 oversupply problem.

The threat layer is more concentrated than usual for a branded food company. The most direct threat is the one already playing out: subcategory price competition. As more producers enter the pasture-raised and outdoor-access egg market, the subcategory faces a price-gap widening problem. CEO Russell Diez-Canseco disclosed on the Q1 2026 call that the gap between Vital Farms' retail pricing and competitors "reached levels that our brand could not sustain." That is not brand weakness - it is the category ceiling effect when premium pricing reaches a threshold the target consumer will not cross. The competitive surface includes Happy Egg and Pete & Gerry's / Nellie's in the pasture-raised and free-range subcategories, plus private-label pasture-raised eggs at major grocers.

HPAI recurrence is the binary threat that no management team can plan around. If a significant HPAI event hits the pasture-raised subcategory specifically, the supply disruption would be more severe for outdoor-access producers than for conventional or cage-free producers. A second material wave at the scale of FY2024 would be net positive for pricing in the short term but creates operational disruption that compounds with the Q1 2026 cleanup.

Securities class actions filed in February-May 2026 (by multiple plaintiff law firms) allege Vital Farms concealed material weaknesses in internal controls and ERP rollout disruptions. These are allegations, not adjudicated facts. The FY2024 material weakness was remediated by December 28, 2025, per the 10-K FY2025. The class action overhang is a real cost (legal fees, management bandwidth, potential settlement) but not an existential risk given the balance sheet position.

Section 6 - The macro environment

Vital Farms is flying through three distinct macro forces simultaneously, and two of them are pointing in opposite directions.

The structural consumer demand for premium and ethical food is the long-term tailwind. Organic and specialty egg sales have grown consistently for a decade, and the "clean label" consumer trend that drove Vital Farms' original Whole Foods distribution continues to expand into mainstream grocery channels. The approximately 16 million U.S. households that have purchased Vital Farms products represent a fraction of total U.S. egg-buying households, meaning penetration growth has room to run without saturating the addressable market.

The egg-price and HPAI cycle is the volatile overlay. HPAI-driven supply disruptions depopulated more than 40 million laying hens across the US industry in 2024, producing historically elevated conventional egg prices - at times creating empty shelf space at retail that benefited premium alternatives. When that HPAI wave receded and producers rebuilt flocks, conventional egg prices normalized and the pasture-raised subcategory found itself with more supply than the premium shelf could absorb at existing prices. The Q1 2026 oversupply is the downstream consequence of a supply-demand cycle driven by disease management in conventional production, which Vital Farms neither caused nor controlled.

The tariff environment added a new layer in FY2025. The 10-K FY2025 added a dedicated tariff risk section for the first time, citing exposure in egg carton packaging (imported from Missouri, Canada, and Europe) and in the butter supply chain. The butter exit resolves the most acute tariff and FX exposure. But egg carton packaging remains a sole-source, partially-imported dependency - the 10-K discloses: "We source substantially all of our shell egg cartons from a sole source supplier, and any disruptions may impact our ability to sell our eggs." In a tariff-volatile environment, that single supplier dependency carries more risk than it did in 2023.

Feed commodity costs - corn and soybean meal - are the input line that flows directly into Vital Farms' cost structure via the quarterly price adjustments in its farmer contracts. The 10-K estimates that a 10% hypothetical change in weighted-average feed costs would have changed FY2025 cost of goods sold by approximately $12.9M. That is a meaningful sensitivity on a company that generated $88M in operating income. The Russia-Ukraine conflict's effect on grain prices has eased since FY2023, but feed cost remains the primary variable cost exposure.

Section 7 - The CFO verdict and the operator bridge

Here is the read on Vital Farms from a CFO's vantage point.

The business model is structurally sound. A 37.6% gross margin, sustained over two consecutive fiscal years, earned through genuine brand pricing power in a commodity category is not a fluke. The farm network, the traceability infrastructure, the Certified B-Corp positioning, and the 24,000-store distribution footprint all represent years of capital and relationship investment that a competitor cannot replicate in a quarter. The 30.6% revenue CAGR from FY2021 to FY2025 confirms that the demand for what Vital Farms is selling has been real and durable. As we discussed in our Hims & Hers teardown, the test of a business model is not whether a good quarter can happen - it is whether the structure that produced that good quarter is something you built or something that was lent to you.

The Q1 2026 print is what happens when the two-sided bet lands on the wrong side simultaneously. The pasture-raised premium requires outdoor birds; outdoor birds carry higher HPAI exposure. The subcategory priced in the HPAI benefit while the industry was depleting flocks; when the industry recovered capacity faster than expected, the subcategory overbuilt. Vital Farms cannot defend its retail shelf price during an oversupply without dumping the excess at $0.10/dozen in the breaker market - and that channel mix shift is what produced the 1,020-basis-point margin compression. The $82M capex on Vital Crossroads was sized for a demand trajectory that now looks like it got pulled forward by the HPAI price cycle.

The balance sheet is the one thing that makes this survivable on a two-year timeline. Zero long-term debt, $103M net cash at FY2025 year-end, an undrawn $60M revolver, and a management team that cut capex guidance by 50% within one quarter of seeing the oversupply data - that is the right set of responses. The question is not whether Vital Farms survives. It is whether the 37.6% gross margin is recoverable once the breaker overhang clears and Vital Crossroads comes online.

The operator bridge. Your $5-80M food or consumer brand very likely has a version of the Vital Farms pattern - smaller in magnitude, but structurally the same. The tell is this: the same thing that earns your premium is the thing most exposed when your supply-demand balance shifts. Vital Farms' outdoor-bird standard is the brand. It is also the HPAI surface. The farm network is the supply resilience. It is also the thing that overbuilt when the demand signal was distorted by a disease cycle.

I have seen this dynamic in client work where a brand's premium was built on a supply constraint - a certification, a sourcing standard, an ethical posture - and the premium held until the constraint eased. When it did, the margin gap between the premium brand and the mainstream alternatives narrowed faster than the brand could respond. The early warning is not in the revenue line. It is in the gross margin trend, specifically in whether the price/mix component of your growth is staying positive while your volume is growing. When volume grows and price/mix goes negative in the same quarter - the way Vital Farms showed in Q1 2026, with +$34.7M volume and -$9.7M price/mix - the premium is being competed away faster than you are replacing it.

Early-warning scorecard - five lines that catch this 12 months early:

1. Price/mix direction vs. volume growth: if both move up together, the brand is compounding. If volume is growing and price/mix is turning negative, the premium is eroding faster than you are scaling.
2. Inventory days outstanding vs. prior year: Vital Farms' DIO went from 23 days (FY2024) to 51 days (FY2025) to 61 days (Q1 FY2026). The inventory build was visible in the annual filing before Q1 2026 confirmed the overcorrection.
3. Operating cash flow vs. net income: when OCF falls materially below net income (Vital Farms: $66M net income in FY2025, only $33.7M OCF), working capital is absorbing the business. Find out what is getting longer: inventory or receivables.
4. Capex as a share of OCF: when capex exceeds operating cash flow for more than two consecutive years, you are funding the capital cycle from your cash reserves, not your operations. Model the cash burn duration at the current run rate.
5. Customer concentration in accounts receivable: when your top 4 customers each represent 10-16% of AR (as Vital Farms' FY2025 10-K discloses), a single payment delay or a renegotiation at one customer changes your cash position materially.

If you want to run this scorecard against your own numbers before you reach a Q1 2026 moment of your own, that is a fractional CFO conversation. The analysis takes a few hours. The cost of not doing it arrives in the quarter when the gross margin moves 10 points in the wrong direction.

Related reading. For the same margin math at DTC-native food brands, see our Magic Spoon teardown, our Graza teardown, and our Fly By Jing teardown.

Sources and methodology

SEC EDGAR is the primary source for every financial figure in this post. Vital Farms, Inc. (CIK 0001579733) files on SEC EDGAR under the 10-K and 10-Q form types. The specific filings used: 10-K FY2025 (filed 2026-02-26, accession 0001193125-26-073423); 10-Q Q1 FY2026 (filed 2026-05-07, accession 0001193125-26-210356); 10-K FY2024 (filed 2025-02-27, accession 0000950170-25-028365); and 10-K FY2023 (filed 2024-03-07, accession 0000950170-24-027602). Revenue, gross margin, operating income, net income, OCF, inventory, PP&E, and all balance sheet figures are taken directly from XBRL financial statements in these filings. The five-year CAGR of 30.6% is stated verbatim in 10-K FY2025 Item 1. Quarterly operating income figures are from the 10-Q filings for Q1-Q3 FY2025 and the Q1 FY2026 10-Q; implied Q4 FY2025 operating income ($88.4M FY2025 total less $21.8M Q1, $23.8M Q2, $21.4M Q3 = implied ~$21.4M Q4) is derived and not independently confirmed.

Our research provided the business model, strengths/weaknesses, competitive map, and macro analysis. It was run against the 10-K FY2025 and 10-Q Q1 FY2026 as primary sources, with Vital Farms investor relations press releases and earnings call transcripts as secondary sources. The Q1 2026 earnings call transcript (investing.com, May 7, 2026) provided the CFO Thilo Wrede verbatim "$0.10 per dozen" breaker channel disclosure and the $32M oversupply management cost figure. Where claims could not be reconciled to a primary filing or dated press, they were excluded.

The Q1 2026 earnings press release and guidance revision (investors.vitalfarms.com, May 7, 2026) provided the FY2026 guidance revision ($775M-$800M revenue, $0M-$10M Adjusted EBITDA, $70M-$75M capex) and the butter wind-down announcement. Prior FY2026 guidance ($900M-$920M revenue, $105M-$115M Adjusted EBITDA) is sourced to the FY2025 Q4 earnings release (February 26, 2026).

Cal-Maine Foods gross margin comparison is sourced to Cal-Maine Foods Q4 and FY2024 results (egg-news.com, July 23, 2024): gross margin of 29.1% in Q4 FY2024, 28.8% in Q4 FY2023. This is the most recent period-matched comparison available; Cal-Maine's quarterly margins are more volatile than Vital Farms' because they are more directly exposed to conventional egg spot prices.

The securities class action disclosures are sourced to investor relations press releases and news coverage (Pomerantz, Schall, Berger Montague and others, February-May 2026). These are allegations, not adjudicated findings. The FY2024 material weakness and its FY2025 remediation are stated in the 10-K FY2025 Item 9A.

Social signal is colour only. The three TikTok embeds in Section 2 are from the pasture-raised-eggs category and carry no financial claim. @paulsaladinomd2 (775K plays), @zephzoid (365.5K plays, 1,117 comments), and @regenroots_ (219.3K plays) were selected as illustrative of the demand culture, the consumer scrutiny, and the competitive landscape for the category. They are not evidence of any revenue or margin figure.

Limitations. Vital Farms does not disclose revenue by retailer (only UNFI/Customer A at 22% and Customer B at 10% are flagged), making precise channel concentration analysis from the filings alone incomplete. The securities class actions are ongoing; outcomes are unknown. The Vital Crossroads facility has not yet generated revenue; all forward-looking statements about it are management guidance, not reported results. The butter wind-down is in process; final financial impact will be reported in Q3 and Q4 FY2026 results. This post reflects filings and disclosures current through June 23, 2026.

Frequently asked questions

is vital farms actually profitable?

In FY2025 Vital Farms posted $66.3M net income and $88.4M operating income on $759M revenue - that profitability is real. In Q1 2026, following an oversupply of pasture-raised eggs that pushed volume into low-priced breaker channels at $0.10/dozen and operational disruption from an ERP rollout, the company posted a $2.3M operating loss and $1.5M net loss. Management guided FY2026 Adjusted EBITDA to $0-$10M. The underlying brand and margin structure are intact; the question is how quickly the oversupply clears.

what happened to vital farms' gross margin in q1 2026?

Gross margin fell from 38.5% in Q1 2025 to 28.3% in Q1 2026, a 1,020 basis-point collapse in a single year. Two drivers: (1) an oversupply of pasture-raised eggs forced the company to sell excess inventory through industrial breaker channels at prices as low as $0.10 per dozen, compressing realized revenue per unit; (2) costs associated with managing the oversupply - including voluntary farmer contract amendments to reduce flock placements - totalled an estimated $32M for full-year 2026. The ERP rollout also disrupted shelf-execution and caused shelf-space loss at retail, adding to the margin hit.

what is vital crossroads and why does it matter?

Vital Crossroads is Vital Farms' second egg-washing and packing facility, under construction in Seymour, Indiana, and expected to be fully operational in early 2027. It is the company's primary capacity investment for long-term growth, sized to serve the new farm network Vital Farms has been recruiting across the Midwest. In FY2025, capex surged to $82M (from $28.6M in FY2024) almost entirely because of this project. PP&E nearly doubled to $160.6M at FY2025 year-end. Vital Crossroads is the right bet for a company that intends to be much larger by 2030 - but the cash and margin drag is front-loaded, arriving before the facility generates a return.

how does avian influenza affect vital farms differently than conventional egg producers?

Vital Farms' pasture-raised standard requires each hen to have at least 108 square feet of outdoor land and daily outdoor access. That outdoor exposure is structurally greater than caged or cage-free birds, meaning Vital Farms farms carry higher HPAI transmission risk per hen. In FY2024, one Vital Farms farm experienced an HPAI outbreak for the first time, and nine farms experienced Egg Drop Syndrome. The 10-K FY2025 elevated HPAI and biosecurity language in its risk factors. The irony: industry-wide HPAI depopulation in FY2024-2025 lifted conventional egg prices and created demand tailwinds for premium brands like Vital Farms. When HPAI subsided and capacity recovered, the subcategory overbuilt and Q1 2026 oversupply followed.

what is vital farms' customer concentration risk?

UNFI, the wholesale distributor that supplies Whole Foods and other natural retailers, accounted for approximately 22% of Vital Farms' FY2025 net revenue - roughly $167M concentrated in one relationship. A second customer (unnamed, likely a major mainstream grocer) accounted for approximately 10% of FY2025 revenue. Four individual customers each represent 10-16% of accounts receivable. The 10-K FY2025 names customer concentration as a primary risk factor: a renegotiation, private-label substitution, or logistics disruption at the distributor layer translates directly into Vital Farms revenue.

does vital farms have debt?

Essentially no long-term financial debt. At FY2025 year-end, Vital Farms had $10.8M in finance-lease liabilities (equipment and building leases), against $113.4M in cash and marketable securities, for a net cash position of approximately $102.6M. The company operates a $60M JPMorgan revolving credit facility, which was undrawn as of both the FY2025 year-end and the Q1 2026 close. By Q1 2026, cash and marketable securities had declined to $51.4M, reflecting capex spending and the oversupply management costs, but the revolver remained undrawn and both financial covenants were in compliance.

why is vital farms winding down its butter business?

Vital Farms announced on May 7, 2026 that it will wind down its butter business by the end of fiscal 2026. Butter and butter-related products represented approximately 3.4% of FY2025 net revenue ($26.2M). CEO Russell Diez-Canseco cited "the complexity of an international supply chain in a very uncertain global trade backdrop" as a contributing factor. The wind-down is expected to be margin-accretive once complete, and it simplifies the company to a pure-play pasture-raised egg business.

who are vital farms' main competitors?

In the pasture-raised subcategory: Happy Egg (with Certified Humane pasture-raised positioning) and Pete & Gerry's Organic Eggs / Nellie's Free Range Eggs (both private). In the broader branded egg market: Cal-Maine Foods (CALM) dominates conventional and specialty egg production at far larger scale. The 10-K FY2025 states Vital Farms is "either the number one or two egg brand by retail dollar sales for branded eggs with nine of our ten largest retail customers" against a U.S. pasture-raised retail egg market of approximately $1.3B in 2025. Private-label pasture-raised eggs from major grocers represent a growing competitive surface as the subcategory moves mainstream.